Search
for

    Sort by

    Research 661–690 of 772

    1. Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study Journal of The American Academy of Dermatology · 2021 · 66 citations
    2. Tofacitinib for the Treatment of Severe Alopecia Areata in Adults and Adolescents Journal of Investigative Dermatology Symposium Proceedings · 2017 · 28 citations
    3. 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata Journal of Investigative Dermatology · 2016 · 3 citations
    4. Good efficacy achieved by telitacicept in treatment of systemic lupus erythematosus with alopecia areata Archives of Medical Science · 2024
    5. Effects of the RV3466F lotion on female telogen effluvium: Results from a 16 week, multi-centric, controlled, randomized trial Journal of The American Academy of Dermatology · 2019
    6. Tofacitinib for the treatment of alopecia areata and variants in adolescents Journal of the American Academy of Dermatology · 2016 · 139 citations
    7. Tofacitinib for the treatment of lichen planopilaris: A case series Dermatologic therapy · 2018 · 79 citations
    8. Label Retaining Cells (LRCs) with Myoepithelial Characteristic from the Proximal Acinar Region Define Stem Cells in the Sweat Gland PLoS ONE · 2013 · 36 citations
    9. Dupilumab induces hair regrowth in pediatric alopecia areata: a real-world, single-center observational study Archives of Dermatological Research · 2024 · 20 citations
    10. Nail involvement in patients with moderate-to-severe alopecia areata treated with oral tofacitinib Journal of Dermatological Treatment · 2018 · 9 citations
    11. Comparison of Dermatology Life Quality Index Scores in Adults and Adolescents with Alopecia Areata Dermatology and Therapy · 2025 · 2 citations
    12. Alopecia Areata and Alopecia Areata Incognita Elsevier eBooks · 2018 · 1 citations
    13. Editorial: Exploring innovative therapies for rare inflammatory skin diseases Frontiers in Medicine · 2026
    14. The genetic basis of dermatophytosis skin infection susceptibility Nature Communications · 2026
    15. Evidence Synthesis Gone Awry: The Perils of Aggregating Ineffective or Unsafe Doses in Alopecia Areata Reviews Cureus · 2026
    16. Hair for the Long Haul: Alopecia Areata Cases and Considerations Dermatology The American Medical Journal · 2025
    17. NUMERICAL DESCRIPTOR COMPUTATION OF ALOPECIA DRUGS USING COM – POLYNOMIAL International Journal of Apllied Mathematics · 2025
    18. Clinical Assessment of Alopecia Areata Severity and Validating the Patient Experience: A Vodcast American Journal of Clinical Dermatology · 2025
    19. Scalp hair cortisol concentration in patients with alopecia areata and correlate its level with the disease variables International Journal of Dermatology Venereology and Leprosy Sciences · 2025
    20. Journal of Population Therapeutics and Clinical Pharmacology 2025
    21. A Concise Review on Novel Drugs Applied in Treatment of Alopecia 2025
    22. Alopecia areata, actualización clínica y terapéutica SPIRE - Sciences Po Institutional REpository · 2024
    23. Líquen plano pilar e alopecia frontal fibrosante: correlação dos achados clínicos e dermatoscópicos com o grau de inflamação do exame histopatológico 2022
    24. A Novel Hope for Alopecia Totalis Patients: Case Report Dubai medical journal · 2020
    25. FRI0157 OBSERVATIONAL STUDY OF HAIR FALL IN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH LOW DOSE METHOTREXATE COMPARED TO HEALTHY CONTROLS Poster presentations · 2019
    26. Patient-Reported Hair Loss and Its Impacts as Measured by the Alopecia Areata Patient Priority Outcomes Instrument in Patients Treated with Ritlecitinib: The ALLEGRO Phase 2b/3 Randomized Clinical Trial American Journal of Clinical Dermatology · 2024 · 4 citations
    27. Patient Profile and Treatment Characteristics of Adults and Adolescents Prescribed Ritlecitinib for Alopecia Areata in the USA Dermatology and Therapy · 2026
    28. Dermatolojik Problemler ve COVID-19 2023
    29. Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications Advances in Therapy · 2023 · 6 citations
    30. Maintenance, withdrawal, and re-treatment with ritlecitinib and brepocitinib in patients with alopecia areata in a single-blind extension of a phase 2a randomized clinical trial Journal of the American Academy of Dermatology · 2021 · 20 citations